Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects

doi:10.1007/s42995-023-00215-9

Review

. 2024 Feb 21;6(2):280-297.

doi: 10.1007/s42995-023-00215-9. eCollection 2024 May.

Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects

D P Nagahawatta¹, N M Liyanage¹, Thilina U Jayawardena², H H A C K Jayawardhana¹, Seong-Hun Jeong³, Hyung-Jun Kwon³, You-Jin Jeon^{1

4}

Affiliations

¹ Department of Marine Life Sciences, Jeju National University, Jeju, 690-756 Republic of Korea.
² Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3 Canada.
³ Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Republic of Korea.
⁴ Marine Science Institute, Jeju National University, Jeju, 63333 Republic of Korea.

PMID: 38827130
PMCID: PMC11136918 (available on 2025-02-21)
DOI: 10.1007/s42995-023-00215-9

Review

Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects

D P Nagahawatta et al. Mar Life Sci Technol. 2024.

. 2024 Feb 21;6(2):280-297.

doi: 10.1007/s42995-023-00215-9. eCollection 2024 May.

Authors

D P Nagahawatta¹, N M Liyanage¹, Thilina U Jayawardena², H H A C K Jayawardhana¹, Seong-Hun Jeong³, Hyung-Jun Kwon³, You-Jin Jeon^{1

4}

Affiliations

¹ Department of Marine Life Sciences, Jeju National University, Jeju, 690-756 Republic of Korea.
² Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3 Canada.
³ Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Republic of Korea.
⁴ Marine Science Institute, Jeju National University, Jeju, 63333 Republic of Korea.

PMID: 38827130
PMCID: PMC11136918 (available on 2025-02-21)
DOI: 10.1007/s42995-023-00215-9

Abstract

A novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has surfaced and caused global concern owing to its ferocity. SARS-CoV-2 is the causative agent of coronavirus disease 2019; however, it was only discovered at the end of the year and was considered a pandemic by the World Health Organization. Therefore, the development of novel potent inhibitors against SARS-CoV-2 and future outbreaks is urgently required. Numerous naturally occurring bioactive substances have been studied in the clinical setting for diverse disorders. The intricate infection and replication mechanism of SARS-CoV-2 offers diverse therapeutic drug targets for developing antiviral medicines by employing natural products that are safer than synthetic compounds. Marine natural products (MNPs) have received increased attention in the development of novel drugs owing to their high diversity and availability. Therefore, this review article investigates the infection and replication mechanisms, including the function of the SARS-CoV-2 genome and structure. Furthermore, we highlighted anti-SARS-CoV-2 therapeutic intervention efforts utilizing MNPs and predicted SARS-CoV-2 inhibitor design.

Supplementary information: The online version contains supplementary material available at 10.1007/s42995-023-00215-9.

Keywords: Drug targets; Inhibitors; Marine natural products; SARS-CoV-2.

© Ocean University of China 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare no conflict of interest. Author You-Jin Jeon is one of the Editorial Board Members, but he was not involved in the journal’s review of, or decision related to, this manuscript.

References

1. Aatif M, Muteeb G, Alsultan A, Alshoaibi A, Khelif BY. Dieckol and its derivatives as potential inhibitors of SARS-CoV-2 spike protein (UK strain: VUI 202012/01): a computational study. Mar Drugs. 2021;19:242. doi: 10.3390/md19050242. - DOI - PMC - PubMed
1. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658. - DOI - PubMed
1. Anderson ED, Thomas L, Hayflick JS, Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J Biol Chem. 1993;268:24887–24891. doi: 10.1016/S0021-9258(19)74548-7. - DOI - PubMed
1. Anjum K, Abbas SQ, Shah SA, Akhter N, Batool S, Hassan SS. Marine sponges as a drug treasure. Biomol Ther (seoul) 2016;24:347–362. doi: 10.4062/biomolther.2016.067. - DOI - PMC - PubMed
1. Astuti I, Ysrafil Y. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020;14:407–412. doi: 10.1016/j.dsx.2020.04.020. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Miscellaneous
- NCI CPTAC Assay Portal

[1] Aatif M, Muteeb G, Alsultan A, Alshoaibi A, Khelif BY. Dieckol and its derivatives as potential inhibitors of SARS-CoV-2 spike protein (UK strain: VUI 202012/01): a computational study. Mar Drugs. 2021;19:242. doi: 10.3390/md19050242. - DOI - PMC - PubMed

[2] Aatif M, Muteeb G, Alsultan A, Alshoaibi A, Khelif BY. Dieckol and its derivatives as potential inhibitors of SARS-CoV-2 spike protein (UK strain: VUI 202012/01): a computational study. Mar Drugs. 2021;19:242. doi: 10.3390/md19050242. - DOI - PMC - PubMed

[3] Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658. - DOI - PubMed

[4] Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658. - DOI - PubMed

[5] Anderson ED, Thomas L, Hayflick JS, Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J Biol Chem. 1993;268:24887–24891. doi: 10.1016/S0021-9258(19)74548-7. - DOI - PubMed

[6] Anderson ED, Thomas L, Hayflick JS, Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J Biol Chem. 1993;268:24887–24891. doi: 10.1016/S0021-9258(19)74548-7. - DOI - PubMed

[7] Anjum K, Abbas SQ, Shah SA, Akhter N, Batool S, Hassan SS. Marine sponges as a drug treasure. Biomol Ther (seoul) 2016;24:347–362. doi: 10.4062/biomolther.2016.067. - DOI - PMC - PubMed

[8] Anjum K, Abbas SQ, Shah SA, Akhter N, Batool S, Hassan SS. Marine sponges as a drug treasure. Biomol Ther (seoul) 2016;24:347–362. doi: 10.4062/biomolther.2016.067. - DOI - PMC - PubMed

[9] Astuti I, Ysrafil Y. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020;14:407–412. doi: 10.1016/j.dsx.2020.04.020. - DOI - PMC - PubMed

[10] Astuti I, Ysrafil Y. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020;14:407–412. doi: 10.1016/j.dsx.2020.04.020. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects

Affiliations

Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

References

Publication types

Related information

LinkOut - more resources

Full Text Sources

Miscellaneous